Literature DB >> 24115809

Transjugular intrahepatic portosystemic shunt for the management of acute variceal hemorrhage.

Romaric Loffroy1, Louis Estivalet, Violaine Cherblanc, Sylvain Favelier, Pierre Pottecher, Samia Hamza, Anne Minello, Patrick Hillon, Pierre Thouant, Pierre-Henri Lefevre, Denis Krausé, Jean-Pierre Cercueil.   

Abstract

Acute variceal hemorrhage, a life-threatening condition that requires a multidisciplinary approach for effective therapy, is defined as visible bleeding from an esophageal or gastric varix at the time of endoscopy, the presence of large esophageal varices with recent stigmata of bleeding, or fresh blood visible in the stomach with no other source of bleeding identified. Transfusion of blood products, pharmacological treatments and early endoscopic therapy are often effective; however, if primary hemostasis cannot be obtained or if uncontrollable early rebleeding occurs, transjugular intrahepatic portosystemic shunt (TIPS) is recommended as rescue treatment. The TIPS represents a major advance in the treatment of complications of portal hypertension. Acute variceal hemorrhage that is poorly controlled with endoscopic therapy is generally well controlled with TIPS, which has a 90% to 100% success rate. However, TIPS is associated with a mortality of 30% to 50% in such a setting. Emergency TIPS should be considered early in patients with refractory variceal bleeding once medical treatment and endoscopic sclerotherapy failure, before the clinical condition worsens. Furthermore, admission to specialized centers is mandatory in such a setting and regional protocols are essential to be organized effectively. This review article discusses initial management and then focuses on the specific role of TIPS as a primary therapy to control acute variceal hemorrhage, particularly as a rescue therapy following failure of endoscopic approaches.

Entities:  

Keywords:  Cirrhosis; Portal hypertension; Transjugular intrahepatic portosystemic shunt; Variceal hemorrhage

Mesh:

Year:  2013        PMID: 24115809      PMCID: PMC3787342          DOI: 10.3748/wjg.v19.i37.6131

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  90 in total

Review 1.  Gastric varices: an updated review of management.

Authors:  Shayan Irani; Kris Kowdley; Richard Kozarek
Journal:  J Clin Gastroenterol       Date:  2011-02       Impact factor: 3.062

2.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

3.  Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage.

Authors:  J Goulis; A Armonis; D Patch; C Sabin; L Greenslade; A K Burroughs
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

4.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

5.  Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis.

Authors:  P S Kamath; M Lacerda; D A Ahlquist; M A McKusick; J C Andrews; D A Nagorney
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

6.  Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.

Authors:  B Bernard; J D Grangé; E N Khac; X Amiot; P Opolon; T Poynard
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  Prognostic factors in upper G.I. bleeding.

Authors:  F T de Dombal; J R Clarke; S E Clamp; G Malizia; M R Kotwal; A G Morgan
Journal:  Endoscopy       Date:  1986-05       Impact factor: 10.093

8.  Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study.

Authors:  Christophe Bureau; Juan Carlos Garcia Pagan; Gilles Pomier Layrargues; Sophie Metivier; Pablo Bellot; Pierre Perreault; Philippe Otal; Juan-G Abraldes; Jean Marie Peron; Hervé Rousseau; Jaume Bosch; Jean Pierre Vinel
Journal:  Liver Int       Date:  2007-08       Impact factor: 5.828

9.  Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage.

Authors:  J Cabrera; M Maynar; R Granados; E Gorriz; R Reyes; J M Pulido-Duque; J L Rodriguez SanRoman; C Guerra; D Kravetz
Journal:  Gastroenterology       Date:  1996-03       Impact factor: 22.682

10.  Economic modelling of early transjugular intrahepatic portosystemic shunt insertion for acute variceal haemorrhage.

Authors:  David J Harman; Roger B McCorry; Ruth P Jacob; Teegan R Lim; Richard O'Neill; Stephen D Ryder; Martin W James; Guruprasad P Aithal; Indra N Guha
Journal:  Eur J Gastroenterol Hepatol       Date:  2013-02       Impact factor: 2.566

View more
  9 in total

Review 1.  Emergent Transjugular Intrahepatic Portosystemic Shunt Creation in Acute Variceal Bleeding.

Authors:  Mithil B Pandhi; Andrew J Kuei; Andrew J Lipnik; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2020-03-04       Impact factor: 1.513

2.  Hepatic venous pressure gradient measurement before TIPS for acute variceal bleeding.

Authors:  Xing-Shun Qi; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 3.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review.

Authors:  Xing-Shun Qi; Ming Bai; Zhi-Ping Yang; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

4.  Simultaneous combined balloon-occluded retrograde transvenous obliteration and partial splenic embolization for gastric fundal varices.

Authors:  Nobuo Waguri; Akihiko Osaki; Shunzo Ikarashi; Masahiro Ogawa; Naosuke Kuraoka; Kohei Ogawa; Munehiro Sato; Tsuneo Aiba; Osamu Yoneyama; Koichi Furukawa; Kazuhito Sugimura; Kentarou Igarashi
Journal:  United European Gastroenterol J       Date:  2015-04-09       Impact factor: 4.623

Review 5.  Outcomes of TIPS for Treatment of Gastroesophageal Variceal Hemorrhage.

Authors:  Ahmad Parvinian; Ron C Gaba
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

6.  Persistence of gastric or esophageal varices on final angiography increases transjugular intrahepatic portosystemic shunt revision rate after polytetrafluoroethylene-covered stent shunt creation.

Authors:  Benjamin Moulin; Olivier Chevallier; Gilles Abdulmalak; Maxime Luu; Marianne Latournerie; Anne Minello; Sophie Gehin; Jean-Pierre Cercueil; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2018-03

Review 7.  Exploration on the Effect of Nonselective β-Receptor Blockers (NSBBs) on Hemodynamic Parameters in Complicated Liver Cirrhosis.

Authors:  Gang Mao; Cong Li; Haiyan Wang; Yong Hong Jv; Yungui Zhang; Lei Liu
Journal:  Biomed Res Int       Date:  2022-04-11       Impact factor: 3.246

8.  Is there a role for stenting in case of acute esophageal variceal bleeding?

Authors:  Gilles Lesur
Journal:  Endosc Int Open       Date:  2014-10-29

9.  Comparative study of endoscopy vs. transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding.

Authors:  Gursimran Singh Kochhar; Udayakumar Navaneethan; Jason Hartman; Jose Mari Parungao; Rocio Lopez; Ranjan Gupta; Baljendra Kapoor; Paresh Mehta; Madhu Sanaka
Journal:  Gastroenterol Rep (Oxf)       Date:  2015-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.